Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for vTv Therapeutics (VTVT) over the last 12 years, with Q3 2025 value amounting to -$10.3 million.

  • vTv Therapeutics' Income from Continuing Operations fell 7714.04% to -$10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$28.4 million, marking a year-over-year decrease of 2496.81%. This contributed to the annual value of -$22.7 million for FY2024, which is 1255.87% up from last year.
  • vTv Therapeutics' Income from Continuing Operations amounted to -$10.3 million in Q3 2025, which was down 7714.04% from -$7.4 million recorded in Q2 2025.
  • In the past 5 years, vTv Therapeutics' Income from Continuing Operations ranged from a high of -$841000.0 in Q2 2021 and a low of -$10.3 million during Q3 2025
  • For the 5-year period, vTv Therapeutics' Income from Continuing Operations averaged around -$6.1 million, with its median value being -$6.0 million (2024).
  • Examining YoY changes over the last 5 years, vTv Therapeutics' Income from Continuing Operations showed a top increase of 8314.97% in 2021 and a maximum decrease of 69010.58% in 2021.
  • vTv Therapeutics' Income from Continuing Operations (Quarter) stood at -$9.5 million in 2021, then soared by 35.78% to -$6.1 million in 2022, then grew by 27.08% to -$4.4 million in 2023, then grew by 0.09% to -$4.4 million in 2024, then tumbled by 133.15% to -$10.3 million in 2025.
  • Its Income from Continuing Operations was -$10.3 million in Q3 2025, compared to -$7.4 million in Q2 2025 and -$6.2 million in Q1 2025.